Cardiovascular Pathology
Volume 19, Issue 2 , Pages e33-e36 , March 2010

Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy

  • Peter Pytel

      Affiliations

    • Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Aliya Husain

      Affiliations

    • Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Ivan Moskowitz

      Affiliations

    • Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
    • Department of Pediatrics, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Jai Raman

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Heather MacLeod

      Affiliations

    • Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Allen S. Anderson

      Affiliations

    • Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Martin Burke

      Affiliations

    • Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA
  • ,
  • Elizabeth M. McNally

      Affiliations

    • Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA
    • Department of Human Genetics, The University of Chicago, Chicago, IL 60637, USA
    • Corresponding Author InformationCorresponding author. 5841 S. Maryland, MC6088, The University of Chicago, Chicago, IL 60637, USA. Tel.: +1 773 702 2672; fax: +1 773 702 2681.

Received 5 February 2008 ,Revised 7 August 2008 ,Accepted 15 September 2008.

References 

  1. Shepler SA, Patel AN. Cardiac cell therapy: a treatment option for cardiomyopathy. Crit Care Nurs Q. 2007;30:74–80
  2. Rosenzweig A. Cardiac cell therapy—mixed results from mixed cells. N Engl J Med. 2006;355:1274–1277
  3. Schachinger V, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–1221
  4. Perin EC, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–2302
  5. Perin EC, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213–II218
  6. Assmus B, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222–1232
  7. Arguero R, et al. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch Med Res. 2006;37:1010–1014

 This work was supported by a grant from the Doris Duke Charitable Foundation to E.M.M.

PII: S1054-8807(08)00125-7

doi: 10.1016/j.carpath.2008.09.004

Cardiovascular Pathology
Volume 19, Issue 2 , Pages e33-e36 , March 2010